SandboxAlonso

Jump to navigation Jump to search
Metipranolol
METIPRANOLOL® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Metipranolol
ClinicalTrials.gov
Metipranolol
Clinical data
Trade namesOptipranolol
AHFS/Drugs.comMicromedex Detailed Consumer Information
MedlinePlusa601078
ATC code
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC17H27NO4
Molar mass309.401 g/mol
3D model (JSmol)
  (verify)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms / Brand Names: METIPRANOLOL

Overview

Metipranolol hydrochloride (OptiPranolol) is a non-selective beta blocker used in eye drops to treat glaucoma.

Category

Beta Blockers

FDA Package Insert

METIPRANOLOL solution/ drops

Indications and Usage | Dosage and Administration | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages

Mechanism of Action

Metipranolol blocks beta1 and beta2 (non-selective) adrenergic receptors. It does not have significant intrinsic sympathomimetic activity, and has only weak local anesthetic (membrane-stabilizing) and myocardial depressant activity.[1]

References

  1. "METIPRANOLOL SOLUTION/ DROPS [FALCON PHARMACEUTICALS, LTD.]".

Template:Antiglaucoma preparations and miotics